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Acute pancreatitis is the second most
common cause of hospital admission
of all gastrointestinal disorders and is
associated with an overall mortality
rate of 0.5 per cent1. Some 351 526
patients were diagnosed with acute
pancreatitis in 2014 in the USA.
First reported in 1901, acute biliary
pancreatitis (ABP) is the second most
common cause of acute pancreatitis in
the Western world and accounts for
40–56 per cent of all cases1–3. ABP is
caused by passage of gallstones leading
to obstruction of the pancreatic duct,
blockage of pancreatic secretion and
increased duct pressure, resulting in
autodigestion followed by a systemic
inflammatory response.
Gallstones occur in up to 20 per cent
of the population and the lifetime risk
for ABP in these individuals is 2–8
per cent. The prevalence of gallstones
in patients with acute pancreatitis is
85–95 per cent. Cholecystectomy in
gallstone carriers lowers the risk of a
first episode of acute pancreatitis to
that of the general population. Man-
agement of ABP only differs from that
of pancreatitis of other aetiologies
when it comes to the question of early
endoscopic retrograde cholangiopan-
creatography (ERCP) and sphinctero-
tomy to restore pancreatic secretion,
and the timing of cholecystectomy.
Reliably diagnosing biliary obstruc-
tion has a major impact on further
clinical management. Transabdomi-
nal ultrasonography has a sensitivity
and specificity of 95–98 per cent for
gallbladder stones, but its sensitiv-
ity for detecting common bile duct
stones is significantly lower. Magnetic
resonance cholangiopancreatography
(MRCP) and endoscopic ultrasound
imaging both have high accuracy for
the diagnosis of stones in the common
bile duct in combination with a high
negative predictive value (Table S1,
supporting information). Exclusion of
persistent biliary obstruction does not
disprove a biliary aetiology for acute
pancreatitis. A typical biochemical
profile in combination with the pres-
ence of gallstones suggests a biliary
cause of pancreatitis with probable
stone passage. However, conflict-
ing results have been reported with
respect to the ability of increased
liver enzyme levels to discriminate
between a biliary and non-biliary ori-
gin of acute pancreatitis; an increase
in alanine aminotransferase level of
at least three times the upper limit
of normal is known to predict ABP
with a positive predictive value of 95
per cent, whereas aspartate amino-
transferase, alkaline phosphatase and
bilirubin have less predictive value
(Table S2, supporting information).
The role of endoscopic interven-
tions as a therapeutic approach to bil-
iary pancreatitis has been under debate
for decades. The American Pancreatic
Association/International Associa-
tion of Pancreatology (APA/IAP)
guidelines3 as well as the British Soci-
ety of Gastroenterology guidelines4
recommend the following evidence-
based clinical indications for ERCP
in ABP: early ERCP is not indicated
in patients with predicted mild biliary
pancreatitis (strong recommendation,
high-quality evidence, grade 1A);
patients with pancreatitis who have
associated cholangitis or persistent
biliary obstruction should undergo
ERCP (strong recommendation,
high-quality evidence, grade 1B);
co-existing biliary obstruction is a
probable indication for early ERCP
(strong recommendation, low-quality
evidence, grade 1C); and early ERCP
seems to have no benefit in patients
with predicted severe biliary pan-
creatitis (strong recommendation,
moderate-quality evidence, grade 1B).
Historically, ERCP with sphinc-
terotomy in biliary pancreatitis was
believed to improve prognosis by
removing remaining common bile
duct stones. A recent meta-analysis
of seven RCTs including 757 patients
found no evidence that early routine
ERCP significantly affects mortal-
ity or local/systemic complications,
regardless of the predicted severity
of biliary pancreatitis5. More recent
RCTs reported relevant confounders
for the efficacy of early ERCP in bil-
iary pancreatitis. RCTs6–8 in patients
without acute cholangitis did not
demonstrate any benefit of early
ERCP with or without sphinctero-
tomy in patients with mild or severe
ABP. Against the background of
spontaneous passage of the majority
of common bile duct stones within
24–48 h, the use of endoscopic ultra-
sound imaging or MRCP before
ERCP supersedes the invasive proce-
dure of ERCP inmore than two-thirds
of patients9. Nevertheless, the indi-
vidual trials, and even the pooled
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data in meta-analyses, did not include
enough patients with ‘predicted severe
biliary pancreatitis without cholangi-
tis’ to study hard clinical endpoints
such as mortality (possible type II sta-
tistical error). Therefore, the Dutch
Pancreatitis Study Group10 initiated
the APEC trial to clarify the role
of early ERCP in patients with pre-
dicted severe biliary pancreatitis in
the absence of cholangitis. Data were
presented to United European Gas-
troenterology 2018. In 230 patients
with predicted severe ABP, early
ERCP with sphincterotomy (less than
24 h after presentation, within 72 h of
symptom onset) was compared with
medical management without endo-
scopic intervention. The combined
primary endpoint was death or severe
complications. There was no statis-
tically significant difference between
groups with regard to the composite
primary endpoint, but a significant
increase was found in the rate of
cholangitis in the medically managed
group. This finding was counterbal-
anced by an increased number of
patients being transferred to ICU
and a significantly increased number
of patients with new-onset respira-
tory failure in the ERCP group. The
authors concluded that, in patients
with predicted severe ABP without
cholangitis, the superiority of early
ERCPwith sphincterotomy compared
with conservative treatment could not
be proved and so early ERCP cannot
be recommended in this group11.
The question of timing of chole-
cystectomy in mild APB to prevent
recurrence was addressed in the
PONCHO (Pancreatitis of biliary
origin: Optimal timiNg of CHOle-
cystectomy) trial12. Based on this
trial, cholecystectomy is recom-
mended during the index admission
in patients with mild ABP. Failure
to remove the gallbladder on index
admission resulted in an increase
in gallstone-related complications
such as pancreatitis, biliary colic and
readmissions, as confirmed in a meta-
analysis13. With respect to conversion
rates from laparoscopy to laparotomy
or surgical complexity, no differ-
ences between groups were detected.
Recommendations for the timing
of cholecystectomy in severe biliary
pancreatitis stem from the IAP/APA
guidelines. Cholecystectomy should
be delayed in patients with an episode
of moderate-to-severe ABP with peri-
pancreatic fluid collections, walled-off
pancreatic necrosis or pseudocysts
until collections have been resolved
or persist beyond 6weeks. Unfortu-
nately, the recommendation is derived
from only two retrospective analyses
and so the level of evidence is low14.
The following recommendations
can be made for management of
ABP. Early ERCP is not indicated
in patients with predicted mild ABP
and has no clinical benefit in those
with predicted severe ABP. Only co-
existing cholangitis is an indication
for early ERCP as co-existing biliary
obstruction is a probable indication
for early ERCP. Cholecystectomy in
patients with mild ABP should be
performed on index admission and
delayed in those with severe ABP, but
sphincterotomy can also be regarded
as definitive treatment only in patients
unfit for cholecystectomy.
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